Header image

Session A: Public Health and Epidemiology

Tracks
Track 1
Track 2
Track 3
Wednesday, September 11, 2019
9:00 AM - 10:45 AM
Montreal Ballroom, Level 11

Speaker

Agenda Item Image
Professor Louisa Degenhardt
Scientia Professor And NHMRC Senior Principal Research Fellow
National Drug And Alcohol Research Centre, UNSW Sydney

The changing landscape of drug use globally: Implications for hepatitis C elimination

9:00 AM - 9:20 AM

Biography

Louisa Degenhardt is a UNSW Scientia Professor, NHMRC Senior Principal Research Fellow and Deputy Director at the National Drug and Alcohol Research Centre (NDARC) at UNSW. Louisa conducts diverse epidemiological studies including data linkage studies focusing upon people with extra-medical or dependent opioid use or chronic pain, analysis of large-scale community and clinical surveys, and cohorts of young people. She is currently CI on a NHMRC Program Grant focussed on drug dependence and viral hepatitis in people who use drugs.
Panel

Questions & Discussion

9:20 AM - 9:25 AM

Biography

Agenda Item Image
Professor Margaret Hellard
Program Director
Burnet Institute

Global Progress Towards Hepatitis C Elimination: Success and Challenges

9:25 AM - 9:45 AM

Video Recording

Biography

Professor Margaret Hellard AM is a Deputy Director at the Burnet Institute. Margaret’s principal research interests are in preventing the transmission and improving the management of blood borne viruses, with the ultimate aim to end the AIDS epidemic and eliminate viral hepatitis as a public health threat.
Dr Norah Palmateer
Senior Research Fellow
Glasgow Caledonian University

THE SCOTTISH EXPERIENCE: REDUCTION IN THE POPULATION PREVALENCE OF CHRONIC HCV AMONG PEOPLE WHO INJECT DRUGS ASSOCIATED WITH MAJOR SCALE-UP OF DIRECT-ACTING ANTIVIRAL THERAPY IN COMMUNITY DRUG SERVICES: REAL WORLD DATA

9:45 AM - 10:00 AM

Abstract

Speaker Presentation

Biography

Dr. Norah Palmateer joined Glasgow Caledonian University as a Senior Research Fellow in 2016. Previously, she worked at Health Protection Scotland, principally on the epidemiology of HCV among people who inject drugs. She is an author of over 30 academic papers related to injecting drug use and blood-borne viruses.
Prof. George Kamkamidze
Head of Research Department
Health Research Union

The Georgian experience. Not just cure. The broader benefits of providing hepatitis C treatment in needle and syringe programs services

10:00 AM - 10:10 AM

Biography

George Kamkamidze is a medical doctor practicing in immunology and infectious diseases. He received PhD in immunology and was post-doctoral fellow in molecular virology at Wadsworth center, NY. His research is mostly focused on viral hepatitis and HIV in different risk groups, including PWID. Dr. Kamkamidze is professor of epidemiology and biostatistics at Georgian-American University and director of clinic NeoLab, providing HCV treatment services, including to PWID.
Dr Sigurdur Olafsson
Director of Hepatology
Landspitali University Hospital

The Iceland experience. Getting the band together: The importance of bringing together government, hepatology, infectious diseases, drug and alcohol services and the prison sector to engage with people who inject drugs in hepatitis C care

10:10 AM - 10:20 AM

Speaker Presentation

Video Recording

Biography

Sigurdur Olafsson is Associate Professor of Medicine at the University of Iceland Faculty of Medicine and Director of Hepatology in the Division of Gastroenterology, Landspitali – The National University Hospital of Iceland. Dr. Olafsson currently leads a nationwide hepatitis C treatment program in Iceland.
Panel

Questions & Discussion

10:20 AM - 10:30 AM

Biography

Dr Kari Lancaster
Scientia Senior Research Fellow
Centre For Social Research In Health, UNSW

LIFE AND LOSS IN THE RACE TO ELIMINATION: WHAT DOES VIRAL ELIMINATION POTENTIATE AND WHAT DOES IT LEAVE BEHIND?

10:30 AM - 10:45 AM

Abstract

Speaker Presentation

Biography

Dr Kari Lancaster is a Senior Research Fellow and Scientia Fellow at the Centre for Social Research in Health at UNSW, and an Honorary Associate Professor at the London School of Hygiene and Tropical Medicine. Kari’s research concentrates on ‘evidence-making’ practices and critical approaches to implementation science in health.

Chair

Agenda Item Image
Margaret Hellard
Program Director
Burnet Institute

Matthew Hickman
Professor in Public Health and Epidemiology
Professor in Public Health and Epidemiology

loading